Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 09 Dec 2025 for Akero Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleWilliam Richard White
Insider track record
Disclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
William Richard White: trading record in brief
Filings by William Richard White span 3 companies, the busiest being Akero Therapeutics, Inc., Disc Medicine, Inc. and Ventyx Biosciences, Inc. In total, 46 filings cover trades dated from 3 May 2021 to 9 December 2025.
No open-market purchase appears, only 11 sales worth €510k. The rest of the record consists of 6 share grants and 27 option exercises. In 2025 alone, the filings show no purchases and 4 sales.
Most recently, on 9 December 2025, the filings show a transaction in Akero Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William Richard White
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
10,179 sharesCommon StockSEC:0001193125-25-312109:0
47,573 sharesCommon StockSEC:0001193125-25-312109:1
659 shares@ US$43.021.3% of flowCommon StockSEC:0000950170-25-114664:0
890 shares@ US$23.8681.0% of flowCommon StockSEC:0000950170-25-093319:0
1,634 shares@ US$54.844.3% of flowCommon StockSEC:0000950170-25-088637:0
2,804 shares@ US$53.9957.6% of flowCommon StockSEC:0000950170-25-085672:0
676 shares@ US$44.881.4% of flowCommon StockSEC:0000950170-25-039734:0
24,300 shares0Common StockSEC:0000950170-24-138143:0
2,817 shares@ US$30.794.3% of flowCommon StockSEC:0000950170-24-136018:0
1,756 shares@ US$2.655.8% of flowCommon StockSEC:0000950170-24-133441:0
201 shares@ US$9.862.4% of flowCommon StockSEC:0000950170-24-121732:0
201 shares@ US$9.862.4% of flowCommon StockSEC:0000950170-24-112387:0
639 shares@ US$26.180.8% of flowCommon StockSEC:0000950170-24-106466:0
201 shares@ US$9.862.4% of flowCommon StockSEC:0000950170-24-103979:0
32,671 shares@ US$7.00910.7% of flowCommon StockSEC:0000950170-24-101895:0
201 shares@ US$9.862.4% of flowCommon StockSEC:0000950170-24-090765:0
500 shares@ US$7.0090.2% of flowCommon StockSEC:0000950170-24-086659:0
29,803 shares@ US$7.00910.0% of flowCommon StockSEC:0000950170-24-084733:0
201 shares@ US$9.862.4% of flowCommon StockSEC:0000950170-24-081524:0
2,831 shares@ US$22.643.1% of flowCommon StockSEC:0000950170-24-073188:0
1,756 shares@ US$2.655.6% of flowCommon StockSEC:0000950170-24-069281:0
201 shares@ US$9.862.4% of flowCommon StockSEC:0000950170-24-052876:0
1,756 shares@ US$2.655.7% of flowCommon StockSEC:0000950170-24-044538:0
724 shares@ US$28.331.0% of flowCommon StockSEC:0000950170-24-032265:0
611 shares@ US$20.760.6% of flowCommon StockSEC:0000950170-23-071246:0
25 of 46 declarations
